Search
for

    Sort by

    Research 30 of 48

    1. Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis Multiple sclerosis and related disorders · 2016 · 6 citations
    2. 1495 Dimethyl fumarate ameliorates delayed wound healing due to IL-36Ra deficiency through inhibition of NET formation and oxidative stress Journal of Investigative Dermatology · 2023
    3. Treating Psoriasis: What Is New About Fumaric Acid Esters? European Medical Journal · 2018
    4. Editors' Picks Journal of Investigative Dermatology · 2012
    5. “Nail loss after teriflunomide treatment: A new potential adverse event” Multiple Sclerosis and Related Disorders · 2017 · 6 citations
    6. BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review British Journal of Dermatology · 2025
    7. Dermatological drugs, topical agents, and cosmetics Side effects of drugs annual · 2010 · 2 citations
    8. Clinical Snippets 2003
    9. The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis Journal of Neuro-Ophthalmology · 2018 · 4 citations
    10. Where it all went right 2014 · 1 citations
    11. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    12. Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations AAPS PharmSciTech · 2024 · 29 citations
    13. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    14. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    15. Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? Neurology and Therapy · 2018 · 5 citations
    16. Dermatological medications and local therapeutics Elsevier eBooks · 2014 · 4 citations
    17. Comparative gene expression analysis of nestin-expressing hair follicle-derived cells Scientific Reports · 2026
    18. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    19. Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study 2025
    20. Hair Loss Associated with Teriflunomide Treatment Journal of Multiple Sclerosis and Neuroimmunology · 2023
    21. General Dermatology Springer eBooks · 2017
    22. Case of alemtuzumab-related alopecia areata management in MS Neurology Neuroimmunology & Neuroinflammation · 2018 · 10 citations
    23. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019 · 277 citations
    24. Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis Clinical Therapeutics · 2015 · 39 citations
    25. CuATSM Enhances Wound Repair Without Scarring via Hippo/YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation Journal of Cellular and Molecular Medicine · 2025 · 3 citations
    26. Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes Frontiers in Neurology · 2022 · 35 citations
    27. 1447 Anti-senescence effect of extracellular vesicle from hyaluronic acid primed induced mesenchymal stem cells on aged human dermal fibroblast Journal of Investigative Dermatology · 2023
    28. Macrophage Related Chronic Inflammation in Non-Healing Wounds Frontiers in Immunology · 2021 · 228 citations
    29. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases Cell · 2020 · 227 citations
    30. Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment Advanced Drug Delivery Reviews · 2023 · 90 citations